Compare HUYA & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUYA | MASS |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 572.2M | 498.1M |
| IPO Year | 2018 | 2020 |
| Metric | HUYA | MASS |
|---|---|---|
| Price | $2.26 | $11.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | $3.52 | ★ $13.38 |
| AVG Volume (30 Days) | ★ 626.3K | 343.6K |
| Earning Date | 11-11-2026 | 11-09-2026 |
| Dividend Yield | ★ 5.43% | N/A |
| EPS Growth | N/A | ★ 125.47 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $56,197,000.00 |
| Revenue This Year | $10.15 | $22.97 |
| Revenue Next Year | $7.09 | $19.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.02 | $5.03 |
| 52 Week High | $4.93 | $13.35 |
| Indicator | HUYA | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 49.37 | 54.74 |
| Support Level | $2.22 | $11.14 |
| Resistance Level | $2.55 | $13.35 |
| Average True Range (ATR) | 0.06 | 0.58 |
| MACD | -0.01 | -0.13 |
| Stochastic Oscillator | 36.67 | 30.60 |
Huya officially became independent in 2016 and is headquartered in Guangzhou. It operates a live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. Huya is a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power, as of the end of 2025.
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.